The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lipton, H. L.
Right arrow Articles by Melvold, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lipton, H. L.
Right arrow Articles by Melvold, R.

The Journal of Immunology, Vol 132, Issue 4 1821-1825, Copyright © 1984 by American Association of Immunologists

ARTICLES

Genetic analysis of susceptibility to Theiler's virus-induced demyelinating disease in mice

HL Lipton and R Melvold

Genetic control of resistance and susceptibility to Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice was examined. Mice derived from various crosses between susceptible SJL (S) and resistant C57BL/6 (B6) strains allowed determination of the relative susceptibility contributed by H-2 and non-H-2 genes, as well as allowing segregation of H-2 linked genes. Six of 39 B6SF1 hybrid progeny developed disease, suggesting several possibilities--resistance is dominant and susceptibility recessive but with incomplete penetrance, the incidence of disease is dose dependent and is dictated by the number of "susceptible/resistant" alleles present at one or more loci, or some combination of the two. Data involving the progeny from the B6SF1 hybrids mated to the S parental strain indicated the involvement of more than one locus. The strong correlation between the number of H-2s haplotypes and the incidence of demyelinating disease suggested that at least one of the genes was linked to the H-2 complex; however, other independently segregating (unlinked) loci strongly affected the disease incidence among H-2 identical animals. A gene or genes from the S background was also associated with enhanced virus growth or diminished virus clearance in the central nervous system (CNS). Overall, the observations support a gene dosage model for susceptibility that relates disease incidence to the total number of S alleles at both H-2 and non-H-2 loci.


This article has been cited by other articles:


Home page
 J. Virol.Home page
J. Myoung, Y. Y. Bahk, H. S. Kang, M. C. Dal Canto, and B. S. Kim
Anticapsid Immunity Level, Not Viral Persistence Level, Correlates with the Progression of Theiler's Virus-Induced Demyelinating Disease in Viral P1-Transgenic Mice
J. Virol., June 1, 2008; 82(11): 5606 - 5617.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. E. Libbey, I. Tsunoda, J. L. Whitton, and R. S. Fujinami
Infectious RNA Isolated from the Spinal Cords of Mice Chronically Infected with Theiler's Murine Encephalomyelitis Virus
J. Virol., March 15, 2007; 81(6): 3009 - 3011.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. C. Fuller, B. Kang, H. K. Kang, H. Yahikozowa, M. C. Dal Canto, and B. S. Kim
Gender Bias in Theiler's Virus-Induced Demyelinating Disease Correlates with the Level of Antiviral Immune Responses
J. Immunol., September 15, 2005; 175(6): 3955 - 3963.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Trottier, B. P. Schlitt, A. Y. Kung, and H. L. Lipton
Transition from Acute to Persistent Theiler's Virus Infection Requires Active Viral Replication That Drives Proinflammatory Cytokine Expression and Chronic Demyelinating Disease
J. Virol., November 15, 2004; 78(22): 12480 - 12488.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
E. L. Oleszak, J. R. Chang, H. Friedman, C. D. Katsetos, and C. D. Platsoucas
Theiler's Virus Infection: a Model for Multiple Sclerosis
Clin. Microbiol. Rev., January 1, 2004; 17(1): 174 - 207.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
L. M. Howard, K. L. Neville, L. M. Haynes, M. C. Dal Canto, and S. D. Miller
CD154 Blockade Results in Transient Reduction in Theiler's Murine Encephalomyelitis Virus-Induced Demyelinating Disease
J. Virol., February 1, 2003; 77(3): 2247 - 2250.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
B.-S. Kang, M. A. Lyman, and B. S. Kim
Differences in Avidity and Epitope Recognition of CD8+ T Cells Infiltrating the Central Nervous Systems of SJL/J Mice Infected with BeAn and DA Strains of Theiler's Murine Encephalomyelitis Virus
J. Virol., November 20, 2002; 76(22): 11780 - 11784.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
B.-S. Kang, M. A. Lyman, and B. S. Kim
The Majority of Infiltrating CD8+ T Cells in the Central Nervous System of Susceptible SJL/J Mice Infected with Theiler's Virus Are Virus Specific and Fully Functional
J. Virol., June 5, 2002; 76(13): 6577 - 6585.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Aubagnac, M. Brahic, and J.-F. Bureau
Bone Marrow Chimeras Reveal Non-H-2 Hematopoietic Control of Susceptibility to Theiler's Virus Persistent Infection
J. Virol., May 3, 2002; 76(11): 5807 - 5812.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Trottier, P. Kallio, W. Wang, and H. L. Lipton
High Numbers of Viral RNA Copies in the Central Nervous System of Mice during Persistent Infection with Theiler's Virus
J. Virol., August 15, 2001; 75(16): 7420 - 7428.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. Aubagnac, M. Brahic, and J.-F. Bureau
Viral Load Increases in SJL/J Mice Persistently Infected by Theiler's Virus after Inactivation of the {beta}2m Gene
J. Virol., August 15, 2001; 75(16): 7723 - 7726.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
A. Azoulay-Cayla, S. Syan, M. Brahic, and J.-F. Bureau
Roles of the H-2Db and H-Kb genes in resistance to persistent Theiler's murine encephalomyelitis virus infection of the central nervous system
J. Gen. Virol., May 1, 2001; 82(5): 1043 - 1047.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
Y. Katz-Levy, K. L. Neville, J. Padilla, S. Rahbe, W. S. Begolka, A. M. Girvin, J. K. Olson, C. L. Vanderlugt, and S. D. Miller
Temporal Development of Autoreactive Th1 Responses and Endogenous Presentation of Self Myelin Epitopes by Central Nervous System-Resident APCs in Theiler's Virus-Infected Mice
J. Immunol., November 1, 2000; 165(9): 5304 - 5314.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. K. Burt, J. Padilla, M. C. Dal Canto, and S. D. Miller
Viral Hyperinfection of the Central Nervous System and High Mortality After Hematopoietic Stem Cell Transplantation for Treatment of Theiler's Murine Encephalomyelitis Virus-Induced Demyelinating Disease
Blood, October 15, 1999; 94(8): 2915 - 2922.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
J. G. Pope, C. L. Vanderlugt, S. M. Rahbe, H. L. Lipton, and S. D. Miller
Characterization of and Functional Antigen Presentation by Central Nervous System Mononuclear Cells from Mice Infected with Theiler's Murine Encephalomyelitis Virus
J. Virol., October 1, 1998; 72(10): 7762 - 7771.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
B. S. Kim, R. L. Yauch, Y. Y. Bahk, J.-A. Kang, M. C. Dal Canto, and C. K. Hall
A Spontaneous Low-Pathogenic Variant of Theiler's Virus Contains an Amino Acid Substitution within the Predominant VP1233-250 T-Cell Epitope
J. Virol., February 1, 1998; 72(2): 1020 - 1027.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1984 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1984 by The American Association of Immunologists, Inc. All rights reserved.